Congress thrust financial institutions into the middle of coronavirus aid packages, and now those companies are working to keep themselves from becoming witnesses, targets or defendants in any future fraud investigations.

The Coronavirus Aid, Relief and Economic Security Act, or CARES Act, is historic, both in the amount of money being dispersed with over $2 trillion and the broad range of industries receiving it, according to Edward “Ted” Kang, a partner at Alston & Bird and part of its COVID-19 task force.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]